P2.13. Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Ayman Ullah
Meta Tag
Speaker Ayman Ullah
Topic SCLC & Neuroendocrine Tumors: Biomarkers & Radiomics
mutational landscape
small cell lung cancer
platinum-based chemotherapy
PD-L1 inhibition
genomic testing
TP53 mutations
RB1 alterations
MLL2 mutations
PTEN alterations
Powered By